查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953523

獸用輔料市場－全球產業規模、佔有率、趨勢、機會及預測（依應用、化學類別、動物種類、最終用途、地區及競爭格局分類，2021-2031年）

Veterinary Excipients Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Application, By Chemical Group, By Animal Type, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸用添加劑市場預計將從 2025 年的 21.1 億美元成長到 2031 年的 28.1 億美元，複合年成長率為 4.82%。

這些輔料是藥理學上惰性的物質，與活性成分混合使用，以改善動物用藥品的穩定性、生物利用度和口感。市場擴張的主要驅動力是全球對動物性蛋白質日益成長的需求，以及需要先進治療方案的伴侶動物數量顯著增加。此外，通用感染疾病率的上升也加速了對有效獸藥的需求，從而推動了對功​​能性輔料的需求。根據美國寵物用品協會（APPA）的數據，預計到2024年，美國寵物產業的總支出將達到1,520億美元，飼主對動物福利的堅定經濟投入將支撐該產業的成長。

市場概覽
預測期 2027-2031
市場規模：2025年 21.1億美元
市場規模：2031年 28.1億美元
複合年成長率：2026-2031年 4.82%
成長最快的細分市場 生產動物
最大的市場 北美洲

儘管有這些有利條件，但由於各地區法規結構嚴格且差異較大，市場仍面臨許多挑戰。製造商在遵守FDA和EMA等監管機構制定的複雜合規標準方面面臨諸多挑戰，這會延長研發週期並增加生產成本。這種監管複雜性可能對新型輔料構成重大准入壁壘，抑制創新，並限制新興市場（目前獸藥標準正在製定中）獲得經濟高效的解決方案。

市場促進因素

全球寵物飼養量的增加和動物擬人化的趨勢正在加速對先進口服固體製劑和偏好給藥系統的需求，從根本上改變了獸用輔料的市場結構。隨著寵物飼主越來越將寵物視為家庭成員，關節炎和糖尿病等慢性疾病的治療需求顯著增加，需要長期用藥管理。這一趨勢促使製造商利用先進的功能性添加劑，特別是掩味劑和崩壞，將傳統的動物醫藥轉化為寵物可食用的咀嚼片和零食。對先進獸醫護理的經濟投入也體現在快速成長的保險業。根據北美寵物健康保險協會於2024年4月發布的《2024年產業趨勢報告》，預計2023年北美寵物保險總保費將達到創紀錄的42.7億美元，顯示高品質藥物製劑市場需求旺盛。

同時，集約化畜牧業的擴張也成為推動這一趨勢的重要因素，對疫苗、藥用飼料添加劑和注射劑等產品中使用的經濟高效的添加劑產生了巨大的需求。為了維持高密度畜群的生產力和糧食安全，生產者高度依賴預防性治療，而添加劑則作為關鍵的穩定劑和載體，確保藥物在實際生產條件下的療效。這種依賴性在生產預測中顯而易見。根據美國農業部海外農業局2024年10月發布的《畜牧與家禽：全球市場與貿易》報告，預計2025年全球雞肉出口量將達到創紀錄的1,380萬噸，反映出支撐龐大添加劑市場的生產系統面臨巨大的壓力。主要企業的數據進一步凸顯了該產業對藥品的巨大需求。碩騰公司報告稱，該公司2023會計年度的全年收入在2024年達到85億美元，顯示其龐大的產業規模需要穩定的藥品原料供應。

市場挑戰

嚴格且分散的區域監管環境是限制全球獸用輔料市場成長的主要障礙。製造商必須遵守美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等機構制定的不同合規要求，這些要求通常涉及對輔料安全性和有效性的廣泛且重疊的檢驗流程。這種監管差異顯著增加了生產成本並延長了研發週期，從而減緩了新型輔料在動物醫藥製劑中的應用。這些不斷成長的資源需求構成了重要的准入壁壘，對中小企業的影響尤其嚴重，並阻礙了整個產業的創新速度。

此外，監管核准的複雜性限制了先進治療方案在關鍵市場（這些市場對成本效益最為重視）的廣泛應用。無法快速部署符合規定的製劑直接影響了嚴重依賴現有動物用藥品的終端用戶產業的生產力。根據澳洲動物藥品協會預測，畜牧業預計到2024年將為農業生產貢獻376億美元，這一數字凸顯了規模經濟的重要性，而規模經濟依賴於高品質動物用藥品的高效核准和供應。因此，監管效率低下不僅阻礙了市場擴張，也威脅到這些輔料所支持的產業的經濟穩定。

市場趨勢

隨著獸用生技藥品領域，特別是單株抗體和聚合物疫苗的快速擴張，高純度輔料的研發也正在加速推進。與傳統的小分子藥物不同，這些複雜的製劑需要特殊的穩定劑，例如藥用級界面活性劑、緩衝劑和冷凍保護劑，以在冷凍乾燥和儲存過程中保持其有效性。這項技術需求正推動著對專門用於處理敏感生物成分的生產能力進行大量資本投資，這與標準的化學生產截然不同。根據默克動物保健公司2025年5月發布的題為「默克動物保健公司與堪薩斯州宣布8.95億美元投資」的新聞稿，該公司宣布將投資8.95億美元用於擴建其位於堪薩斯州德索託的工廠，專門用於提升生物製藥和疫苗的灌裝和凍乾能力。

同時，在大型動物用藥品公司嚴格的環境、社會和管治(ESG) 要求的推動下，市場正經歷著向永續和可生物分解輔料的根本性轉變。製造商正加強對其供應鏈的審查，以減少範圍 3 的排放，並優先使用可再生原料而非石油化學衍生的聚合物，從而最大限度地減少其對環境的影響。這項產業範圍內的脫碳策略正在對輔料供應商提出一系列要求，要求他們檢驗其產品的碳足跡和生物分解性，以確保符合關鍵的採購標準。碩騰公司於 2025 年 6 月發布的《2024 年永續發展進展報告》顯示，該公司將使用 80.6% 的全球整體電力來自再生能源來源，這表明綠色轉型正在重塑醫藥原料的採購標準，其規模之大令人矚目。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球獸用輔料市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依應用領域（生物製藥、藥品、藥用飼料添加劑）
    • 依化學基團分類（聚合物、醇類、脂質、無機鹽等）
    • 動物類型（生產動物、伴侶動物）
    • 依用途分類（增溶劑/溶劑、粘合劑、穩定劑、塗層劑、稀釋劑/填料等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲獸用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區獸用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲獸用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美獸用輔料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球獸用輔料市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Croda International plc
  • JRS PHARMA GmbH+Co. KG
  • Colorcon
  • Quality Chemicals SL
  • IOI Oleo GmbH
  • Lipoid GmbH
  • Gattefosse SAS
  • Azelis Group
  • Ashland Global Holdings Inc.
  • Spectrum Chemical Mfg. Corp.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23846

The Global Veterinary Excipients Market is projected to expand from USD 2.11 Billion in 2025 to USD 2.81 Billion by 2031, reflecting a compound annual growth rate of 4.82%. These excipients are pharmacologically inert substances formulated with active pharmaceutical ingredients to improve the stability, bioavailability, and taste of animal health products. The market's expansion is primarily driven by the escalating global demand for animal-derived protein and a substantial increase in companion animal ownership, which requires sophisticated therapeutic options. Furthermore, the rising incidence of zoonotic diseases has accelerated the need for effective veterinary formulations, thereby boosting the demand for functional excipients. Data from the American Pet Products Association indicates that total U.S. pet industry expenditures hit $152 billion in 2024, demonstrating the strong financial dedication of owners to animal welfare that supports this sector's growth.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.11 Billion
Market Size 2031USD 2.81 Billion
CAGR 2026-20314.82%
Fastest Growing SegmentProduction Animals
Largest MarketNorth America

Despite these positive conditions, the market encounters a major hurdle due to strict and varying regulatory frameworks across different regions. Manufacturers face the challenge of adhering to complex compliance standards established by authorities such as the FDA and EMA, which can extend development timelines and inflate production costs. This regulatory complexity acts as a formidable barrier to entry for new excipients, potentially curbing innovation and restricting the availability of cost-effective solutions in emerging markets where veterinary standards are currently evolving.

Market Driver

The trends of rising global pet ownership and the humanization of animals are fundamentally altering the veterinary excipients landscape by accelerating the demand for sophisticated oral solid dosage forms and palatable delivery systems. As pet owners increasingly regard their companions as family members, there is a distinct shift toward treating chronic conditions such as arthritis and diabetes, necessitating long-term medication adherence. This trend compels manufacturers to utilize advanced functional excipients, particularly taste-masking agents and disintegrants, to transform traditional veterinary drugs into pet-friendly chewables and treats. The financial commitment to advanced veterinary care is evident in the surging insurance sector; according to the North American Pet Health Insurance Association's 'State of the Industry Report 2024' released in April 2024, total pet insurance premiums in North America reached a record $4.27 billion in 2023, signaling a robust market for premium pharmaceutical formulations.

Simultaneously, the expansion of intensive livestock farming operations acts as a parallel driver, creating high-volume demand for cost-effective excipients used in vaccines, medicated feed additives, and injectables. To maintain productivity and food security within densely populated herds, producers rely heavily on prophylactic treatments, where excipients act as critical stabilizers and carriers to ensure drug efficacy under field conditions. This reliance is underscored by production forecasts; according to the USDA Foreign Agricultural Service's October 2024 'Livestock and Poultry: World Markets and Trade' report, global chicken meat exports are forecast to rise to a record 13.8 million tons in 2025, reflecting the intense pressure on production systems that sustains the bulk excipient market. The immense scale of pharmaceutical requirements in this sector is further highlighted by leading manufacturers; according to Zoetis, in 2024, the company reported full-year revenue of $8.5 billion for 2023, illustrating the substantial industrial footprint requiring a steady supply of pharmaceutical ingredients.

Market Challenge

The stringent and fragmented regulatory landscape across different regions constitutes a primary obstacle hampering the growth of the Global Veterinary Excipients Market. Manufacturers must adhere to disparate compliance requirements enforced by agencies such as the FDA and EMA, which often necessitates extensive and redundant validation processes for excipient safety and efficacy. This regulatory divergence significantly escalates production costs and prolongs development timelines, thereby reducing the speed at which novel excipients can be integrated into finished veterinary formulations. These elevated resource demands act as a substantial barrier to entry, disproportionately affecting smaller enterprises and stifling the overall rate of innovation within the industry.

Furthermore, the complexity of securing regulatory approval limits the availability of advanced therapeutic options in key markets where cost-efficiency is paramount. The inability to rapidly deploy compliant formulations directly affects the productivity of end-use sectors that rely heavily on accessible veterinary medicines. According to Animal Medicines Australia, in 2024, the livestock industry was forecast to contribute $37.6 billion to agricultural production, a figure that highlights the critical economic volume dependent on the efficient approval and supply of high-quality animal health products. Consequently, regulatory inefficiencies not only hinder market expansion but also threaten the economic stability of the industries these excipients serve.

Market Trends

The development of high-purity excipients is accelerating due to the rapid expansion of the veterinary biologics sector, particularly for monoclonal antibodies and large-molecule vaccines. Unlike traditional small-molecule drugs, these complex formulations require specialized stabilizing agents, such as pharmaceutical-grade surfactants, buffers, and cryoprotectants, to maintain efficacy during freeze-drying and storage. This technical necessity is driving significant capital expenditure in manufacturing capabilities designed specifically to handle sensitive biological ingredients, distinct from standard chemical production. According to Merck Animal Health, May 2025, in the press release 'Merck Animal Health and State of Kansas Announce $895 Million Investment', the company committed $895 million to expand its De Soto, Kansas facility, specifically enhancing filling and freeze-drying capacity for biologics and vaccines.

Concurrently, the market is witnessing a fundamental shift toward sustainable and biodegradable excipients, compelled by the rigorous environmental, social, and governance (ESG) mandates of leading animal health corporations. Manufacturers are increasingly scrutinizing their supply chains to reduce Scope 3 emissions, prioritizing ingredients derived from renewable sources over petrochemical-based polymers to minimize their environmental impact. This industry-wide decarbonization strategy creates a cascading requirement for excipient suppliers to validate the carbon footprint and biodegradability of their portfolios to remain compliant with major procurement standards. According to Zoetis, June 2025, in the '2024 Sustainability Progress Update', the company reported sourcing 80.6% of its global electricity from renewable sources, illustrating the scale of the green transition that is reshaping procurement criteria for pharmaceutical ingredients.

Key Market Players

  • Croda International plc
  • JRS PHARMA GmbH + Co. KG
  • Colorcon
  • Quality Chemicals S.L
  • IOI Oleo GmbH
  • Lipoid GmbH
  • Gattefosse SAS
  • Azelis Group
  • Ashland Global Holdings Inc.
  • Spectrum Chemical Mfg. Corp.

Report Scope

In this report, the Global Veterinary Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Excipients Market, By Application

  • Biologics
  • Pharmaceuticals
  • Medicated Feed Additives

Veterinary Excipients Market, By Chemical Group

  • Polymers
  • Alcohols
  • Lipids
  • Mineral Salts
  • Others

Veterinary Excipients Market, By Animal Type

  • Production Animals
  • Companion Animals

Veterinary Excipients Market, By End Use

  • Solubilizers/ Solvents
  • Binders
  • Stabilizers
  • Coating
  • Diluents & fillers
  • Others

Veterinary Excipients Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Excipients Market.

Available Customizations:

Global Veterinary Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Excipients Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Biologics, Pharmaceuticals, Medicated Feed Additives)
    • 5.2.2. By Chemical Group (Polymers, Alcohols, Lipids, Mineral Salts, Others)
    • 5.2.3. By Animal Type (Production Animals, Companion Animals)
    • 5.2.4. By End Use (Solubilizers/ Solvents, Binders, Stabilizers, Coating, Diluents & fillers, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Excipients Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Chemical Group
    • 6.2.3. By Animal Type
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Excipients Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Chemical Group
        • 6.3.1.2.3. By Animal Type
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada Veterinary Excipients Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Chemical Group
        • 6.3.2.2.3. By Animal Type
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico Veterinary Excipients Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Chemical Group
        • 6.3.3.2.3. By Animal Type
        • 6.3.3.2.4. By End Use

7. Europe Veterinary Excipients Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Chemical Group
    • 7.2.3. By Animal Type
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Excipients Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Chemical Group
        • 7.3.1.2.3. By Animal Type
        • 7.3.1.2.4. By End Use
    • 7.3.2. France Veterinary Excipients Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Chemical Group
        • 7.3.2.2.3. By Animal Type
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom Veterinary Excipients Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Chemical Group
        • 7.3.3.2.3. By Animal Type
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy Veterinary Excipients Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Chemical Group
        • 7.3.4.2.3. By Animal Type
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain Veterinary Excipients Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Chemical Group
        • 7.3.5.2.3. By Animal Type
        • 7.3.5.2.4. By End Use

8. Asia Pacific Veterinary Excipients Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Chemical Group
    • 8.2.3. By Animal Type
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Excipients Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Chemical Group
        • 8.3.1.2.3. By Animal Type
        • 8.3.1.2.4. By End Use
    • 8.3.2. India Veterinary Excipients Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Chemical Group
        • 8.3.2.2.3. By Animal Type
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan Veterinary Excipients Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Chemical Group
        • 8.3.3.2.3. By Animal Type
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Korea Veterinary Excipients Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Chemical Group
        • 8.3.4.2.3. By Animal Type
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia Veterinary Excipients Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Chemical Group
        • 8.3.5.2.3. By Animal Type
        • 8.3.5.2.4. By End Use

9. Middle East & Africa Veterinary Excipients Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Chemical Group
    • 9.2.3. By Animal Type
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Excipients Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Chemical Group
        • 9.3.1.2.3. By Animal Type
        • 9.3.1.2.4. By End Use
    • 9.3.2. UAE Veterinary Excipients Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Chemical Group
        • 9.3.2.2.3. By Animal Type
        • 9.3.2.2.4. By End Use
    • 9.3.3. South Africa Veterinary Excipients Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Chemical Group
        • 9.3.3.2.3. By Animal Type
        • 9.3.3.2.4. By End Use

10. South America Veterinary Excipients Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Chemical Group
    • 10.2.3. By Animal Type
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Excipients Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Chemical Group
        • 10.3.1.2.3. By Animal Type
        • 10.3.1.2.4. By End Use
    • 10.3.2. Colombia Veterinary Excipients Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Chemical Group
        • 10.3.2.2.3. By Animal Type
        • 10.3.2.2.4. By End Use
    • 10.3.3. Argentina Veterinary Excipients Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Chemical Group
        • 10.3.3.2.3. By Animal Type
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Excipients Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Croda International plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. JRS PHARMA GmbH + Co. KG
  • 15.3. Colorcon
  • 15.4. Quality Chemicals S.L
  • 15.5. IOI Oleo GmbH
  • 15.6. Lipoid GmbH
  • 15.7. Gattefosse SAS
  • 15.8. Azelis Group
  • 15.9. Ashland Global Holdings Inc.
  • 15.10. Spectrum Chemical Mfg. Corp.

16. Strategic Recommendations

17. About Us & Disclaimer